Drug-drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 2: clinical trial results.

Journal of Pharmacokinetics and Pharmacodynamics
Marylore ChenelFrance Mentré

Abstract

To compare results of population PK analyses obtained with a full empirical design (FD) and an optimal sparse design (MD) in a Drug-Drug Interaction (DDI) study aiming to evaluate the potential CYP3A4 inhibitory effect of a drug in development, SX, on a reference substrate, midazolam (MDZ). Secondary aim was to evaluate the interaction of SX on MDZ in the in vivo study. Methods To compare designs, real data were analysed by population PK modelling technique using either FD or MD with NONMEM FOCEI for SX and with NONMEM FOCEI and MONOLIX SAEM for MDZ. When applicable a Wald test was performed to compare model parameter estimates, such as apparent clearance (CL/F), across designs. To conclude on the potential interaction of SX on MDZ PK, a Student paired test was applied to compare the individual PK parameters (i.e. log(AUC) and log(C(max))) obtained either by a non-compartmental approach (NCA) using FD or from empirical Bayes estimates (EBE) obtained after fitting the model separately on each treatment group using either FD or MD. For SX, whatever the design, CL/F was well estimated and no statistical differences were found between CL/F estimated values obtained with FD (CL/F = 8.2 l/h) and MD (CL/F = 8.2 l/h). For MDZ, only MON...Continue Reading

References

Dec 14, 1999·European Journal of Clinical Pharmacology·J C KrayenbühlP Dayer
Nov 16, 2002·International Immunopharmacology·Kenneth L Hastings, UNKNOWN Center for Drug Evaluation and Research, US Food and Drug Administration
Nov 20, 2002·Cancer Chemotherapy and Pharmacology·Jing Li, Peter Gwilt
Feb 6, 2004·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rashmi R Shah
Jan 11, 2007·Journal of Pharmacokinetics and Pharmacodynamics·Marc Lavielle, France Mentré
Jan 30, 2007·Clinical Pharmacology and Therapeutics·S-M HuangL J Lesko
Feb 13, 2007·Computer Methods and Programs in Biomedicine·Ivelina GueorguievaLeon Aarons
Apr 4, 2007·European Journal of Clinical Pharmacology·Emmanuelle CometsFrance Mentré
Aug 4, 2009·The AAPS Journal·Radojka M Savic, Mats O Karlsson

❮ Previous
Next ❯

Citations

Feb 20, 2013·Journal of Pharmacokinetics and Pharmacodynamics·Alan MaloneyMarloes Schaddelee
Jul 19, 2011·Expert Opinion on Drug Metabolism & Toxicology·Andrea N Edginton, Ghanashyam Joshi
Aug 2, 2011·International Journal of Pharmaceutics·Wenlei JiangLawrence X Yu
Jan 28, 2010·Basic & Clinical Pharmacology & Toxicology·Leon Aarons, Kayode Ogungbenro
Jun 14, 2016·European Journal of Drug Metabolism and Pharmacokinetics·Khaled S AbdlekawyFawzy Elbarbry

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.